A low frequency mutation detected in lung and gastric cancer. Functional significance of this alteration has not yet been described. However, a single NSCLC patient with this mutation in a clinical trial shows partial response to gefitinb therapy
Citations
Liu et al..Epidermal growth factor receptor mutation in gastric cancer.Pathology. 2011 Apr;43(3):234-8